Fast and repeated assessments of tumor sensitivity to available drugs can improve clinical outcomes by staying ahead of a cancer's ability to resist certain therapies

A novel personalized vaccine made using patients’ tumor tissue and immune cells stimulates potent therapeutic immune responses, extending overall survival of patients with recurrent ovarian cancer

U-M researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: extended relief from peanut allergies

The miniaturized imaging and sensing probe has been developed to help study drug-induced hyperthermia

New platform aims to improve immunoassay workflow, flexibility, and speed in biotherapeutic discovery, development, and production

Real-time polymerase chain reaction (PCR) and reverse transcription PCR kits amplify nucleic acids, DNA and RNA respectively, from laboratory samples, allowing clinicians to diagnose infections with just a small sample from patients

Researchers found that many of the chemicals used to flavor e-cigarettes increased the production of free radicals, while a few actually lowered it

Scientists have created a non-invasive, adhesive patch, which promises the measurement of glucose levels through the skin without a finger-prick blood test

Early lab-based tests of a recently developed drug were successful in targeting resistant breast cancers and indicated minimal side effects

The SCIEX Citrine™ MS/MS medical device provides clinical labs with one solution to tackle today’s difficult assays, and the versatility to address tomorrow’s precision medicine and wellness testing